Published Jun 28, 2024

AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'

Explore the transformative power of AI in drug development through Formation Bio's substantial funding, VW's surprising billion-dollar partnership with Rivian, and the rise of the fediverse as a decentralized social media alternative post-Elon Musk's Twitter acquisition.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

AI is going to make Big Tech even bigger, and richer
Answers 383 questions
AI Friends, deepfake foes, and which Tiger Global partner is leaving now
Answers 383 questions
AI's busy week, and why the heck are so many VCs leaving their firms?
Answers 383 questions
AI talent managers, technocapitalist college towns, and a rise in defense tech acquisitions
Answers 383 questions
Ilya Sutskever's new AI venture, and time to BeReal about bankruptcy
Answers 383 questions
The AI industry's 'next big bet,' and should we just buy Chrome?
Answers 383 questions
OpenAI's DevDay, reinventing the REIT and good actors in crypto
Answers 383 questions
Are AI companies just defense tech now?
Answers 383 questions
The new Equity crew on a proposed AI 'kill switch' and why it's rough out there for VCs
Answers 383 questions
Match Group’s deal with OpenAI is just business with AI glitter on top
Answers 383 questions
AI for landlords, Grok-2 unleashed, and the latest attempt at AI regulation
Answers 383 questions
Inside TC’s Techstars investigation and how AI is accelerating disability tech
Answers 383 questions
AI ‘no one wants’ and Google’s potential breakup
Answers 383 questions
The race isn’t over for European AI startups, according to Accel Parther Philippe Botteri
Answers 383 questions
Community is the new AI
Answers 383 questions

Dexa/Equity

AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'

Topics covered

Popular Clips

Rivian and VW Partnership

AI in Drug Discovery

Predictive AI Trends

AI in Drug Development

Volkswagen's Software Struggles

Twitter Alternatives Explored

Transformative Banking Deals

Legal Challenges Ahead

Exploring the Fediverse

Rise of the Fediverse

DEI Challenges Unveiled

Episode Highlights

AI Drug Development

Rivian and VW

Fediverse Growth

Related Episodes

AI is going to make Big Tech even bigger, and richer

AI Friends, deepfake foes, and which Tiger Global partner is leaving now

AI's busy week, and why the heck are so many VCs leaving their firms?

AI talent managers, technocapitalist college towns, and a rise in defense tech acquisitions

Ilya Sutskever's new AI venture, and time to BeReal about bankruptcy

The AI industry's 'next big bet,' and should we just buy Chrome?

OpenAI's DevDay, reinventing the REIT and good actors in crypto

Are AI companies just defense tech now?

The new Equity crew on a proposed AI 'kill switch' and why it's rough out there for VCs

Match Group’s deal with OpenAI is just business with AI glitter on top

AI for landlords, Grok-2 unleashed, and the latest attempt at AI regulation

Inside TC’s Techstars investigation and how AI is accelerating disability tech

AI ‘no one wants’ and Google’s potential breakup

The race isn’t over for European AI startups, according to Accel Parther Philippe Botteri

Community is the new AI

AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'

Topics covered

Popular Clips

Episode Highlights

AI Drug DevelopmentHaje Kamps discusses Formation Bio's $372 million Series D funding round, emphasizing its role in advancing AI-driven drug development. The conversation explores how AI models, including custom LLMs and partnerships with OpenAI, are revolutionizing the pharmaceutical industry.

AI Drug Development

Rivian and VWThe partnership between Rivian and Volkswagen Group has taken the automotive world by surprise. Volkswagen's initial $1 billion investment into Rivian is part of a broader software development deal, which could potentially scale up to $5 billion.

Rivian and VW

Fediverse GrowthNext, Kirsten Korosec explores the fediverse, a decentralized network of social media platforms gaining traction. She discusses how Elon Musk's acquisition of Twitter has driven increased interest and adoption of these alternative platforms.

Fediverse Growth

Related Episodes